Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 6/24/12  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. John W. Goethe MD

Wrong Dr. John W. Goethe MD?

Board Member

Email: j***@***.org
Burlingame Center for Research and Education at the Institute of Living

Employment History

Board Memberships and Affiliations


  • MD
  • M.D.
    Medical College of South Carolina
54 Total References
Web References
Seymour Street Journal - 6/24/2012 - Hartford Hospital, Connecticut, 24 June 2012 [cached]
Dr. John Goethe, director of the Burlingame Center for Psychiatric Research and Education at the Institute of Living, was the keynote speaker at the annual meeting of the Farmington Valley Chapter of the National Alliance on Mental Health (NAMI) June 19 at the Farmington Library. He spoke on "Transcranial Magnetic Stimulation (TMS), a non-invasive treatment for depression."
Seymour Street Journal - 10/30/2011 - Hartford Hospital, Connecticut, 30 Oct 2011 [cached]
Dr. John Goethe Delivers Paper in Buenos Aires at World Congress of Psychiatry
Dr. John Goethe, director of the Burlingame Center for Research and Education at the Institute of Living, delivered a paper at the World Psychiatric Association's 15th World Congress of Psychiatry in Buenos Aires, Argentina on Sept 20. His paper was entitled "Psychodynamic Issues in Healthcare Research."
Seymour Street Journal - 4/1/2012 - Hartford Hospital, Connecticut, 1 April 2012 [cached]
Dr. John Goethe, director of clinical research at the Burlingame Center for Psychiatric Research at the IOL, is conducting a new trial using a new, non-invasive medical device for the treatment of depression known as low emission NeoSync EEG synchronized transcranial magnetic stimulation (sTMS). Inclusion criteria for the trial include a diagnosis of Major Depressive Disorder, failure to respond to exactly one medication in the current Major Depressive Episode and age between 22 and 65 years old. he trial consists of five 30-minute treatments per week for six weeks.
In addition, Dr. Goethe recently made a presentationat a psychopharmacology conference sponsored by the Nevada Psychiatric Association regarding antipsychotic prescribing practices for patients under age 18. The study, thought to be the largest of its kind, was undertaken at the Institute of Living. "This is an important issue because these antipsychotic medications are commonly prescribed," said Dr. Goethe. The amount of published data about antipsychotic use in children and adolescents who are inpatients is scant, he said, and antipsychotics are commonly used for indications that have not been approved by the FDA.
John W. Goethe, M.D., ..., 10 Mar 2010 [cached]
John W. Goethe, M.D., Director of Burlingame Center for Psychiatric Research and Education, The Institute of Living/Hartford Hospital
John W. Goethe, M.D., ..., 19 Jan 2008 [cached]
John W. Goethe, M.D., Medical Director, Professional Education; Director, the Burlingame Center, The Institute of Living/Hartford HospitalClick here for abstract, objectives, and reference list.
Other People with the name "Goethe":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.